Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

On June 3, Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE: HUM) and a $313 price ...

“We were pleased with Humana’s solid finish to the year while also reaffirming our outlook for 2025,” CEO Jim Rechtin remarked. As for Q4 financials, the Louisville, Kentucky-based managed ...

Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare ...

Shares of PVH Corp. fell after hours on Wednesday after the Calvin Klein and Tommy Hilfiger parent cut its full-year profit outlook, citing the impact of tariffs on shipments heading into the U.S. The ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

But, less than two months later, the company is in a state of free fall. Its collapse reflects not simply the troubles of the ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst ...

Per WSJ’s forecasting data, the average UNH price target is $378.86 per share. Given that the current UNH price is $292.80 ...

UnitedHealth Group Inc UNH is witnessing robust growth in its medical membership, reflecting a strong demand for both ...

With the official start of the 2025 Atlantic hurricane season just days away, forecasters and communities alike are turning their attention to what could be another highly active year. The ...